Browsing by Author Davis, T. M. E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2007Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialKeech, Anthony (Tony); Merrifield, Alistair; Mitchell, Ronald (Paul); Moffitt, Mireille; O'Connell, Rachel; Simes, Robert John; Tse, D; Williamson, E; Crimet, D. C.; Davis, T. M. E.; D'Emden, MC; Laatikainen, LT; O'Day, J; Summanen, PA; Taskinen, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Clinical Ophthal & Eye Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial, The Lancet, vol.370,(9600),2007,pp 1687-1697
2010Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDonoghoe, Mark; Gebski, Val; Keech, Anthony (Tony); O'Connell, Rachel; Simes, Robert John; Ting, R; Best, J; Davis, T. M. E.; Drury, P.L.; Glasziou, Paul .P.; Jenkins, Alicia J.; Kesaniemi, Y. Antero; Scott, R; Sullivan, D; Whiting, M. J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study, Diabetologia: clinical and experimental diabetes and metabolism, vol.54, 2,pp 280-290
2011Estimated Glomerular Filtration Rate and Albuminuria are Independent Predictors of Cardiovascular Events and Death in Type 2 Diabetes Mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDrury, Paul; Keech, Anthony (Tony); Pardy, Christopher; Ting, Ru Dee; Zannino, Diana; Ansquer, Jean-Claude; Colman, P. G.; Davis, T. M. E.; Dixon, P; Ehnholm, Christian; Fassett, Robert; Flack, Jeff; Whiting, M. J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEstimated Glomerular Filtration Rate and Albuminuria are Independent Predictors of Cardiovascular Events and Death in Type 2 Diabetes Mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study, Diabetologia: clinical and experimental diabetes and metabolism, vol.54, 1, 2011,pp 32-43
2008Fenofibrate and diabetic retinopathy - Authors' replyKeech, Anthony (Tony); Mitchell, Paul (Ronald); Simes, Robert John; Davis, T. M. E.; Summanen, PA; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; School of Public Health: NH&MRC Clinical Trials CentreFenofibrate and diabetic retinopathy - Authors' reply, The Lancet, vol.371,(9614),2008,pp 722-722
2016Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohortsMitchell, Paul; Woodward, Mark; Adams, Robert J T; Anstey, Kaarin J.; Balkau, Beverley J; Brennan-Olsen, Sharon; Briffa, Tom; Davis, T. M. E.; Davis, Wendy A.; Dobson, Annette; Giles, Graham; Grant, Janet; Harding, Jessica; Huxley, Rachel R; Knuiman, Matthew; Luszcz, Mary; Magliano, Dianna J; Pasco, Julie A.; Reid, Chris; Shaw, Jonathan E; Simmons, D; Simons, Leon; Sooriyakumaran, Manoshayini; Taylor, Anne; Tonkin, Andrew; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global HealthHypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts, Journal of Hypertension, vol.34, 1, 2016,pp 149-155
2011Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialDonoghoe, Mark; Fulcher, Greg; Keech, Anthony (Tony); Pardy, Christopher; Colman, P. G.; Davis, T. M. E.; Manning, Patrick; O'Brien, Richard; Scott, Russell; Taskinen, M.; Watts, Gerald F.; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreImpact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial, Cardiovascular Diabetology, vol.10, 1, 2011,pp 102-1-102-8
2014Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trialChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Van Dieren, Susan; Woodward, Mark; Zoungas, Sophia; Beulens, Joline W. J.; Davis, T. M. E.; Fulcher, Greg R.; Hamet, Pavel; Heller, Simon; Mancia, Giuseppe; Marre, Michel; Peelen, Linda; van der Schouw, Yvonne T; Williams, Bryan; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthIntensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial, Diabetes, Obesity and Metabolism, vol.16, 5, 2014,pp 426-432
2015The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?Mitchell, Paul; Woodward, Mark; Adams, Robert J; Anstey, Kaarin; Balkau, Beverley J; Briffa, Tom; Davis, T. M. E.; Davis, Wendy; Dobson, Annette; et al, Various; Giles, Graham; Harding, Jessica; Sooriyakumaran, Manoshayini; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global HealthThe metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?, Diabetes and Metabolism, vol.41, 6, 2015,pp 463-469